InChI=1S/C49H83O13P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 21- 23- 25- 27- 29- 31- 33- 35- 37- 42(50) 59- 39- 41(40- 60- 63(57,58) 62- 49- 47(55) 45(53) 44(52) 46(54) 48(49) 56) 61- 43(51) 38- 36- 34- 32- 30- 28- 26- 24- 22- 20- 18- 16- 14- 12- 10- 8- 6- 4- 2/h17- 20,23- 26,29- 32,41,44- 49,52- 56H,3- 16,21- 22,27- 28,33- 40H2,1- 2H3,(H,57,58) /b19- 17- ,20- 18- ,25- 23- ,26- 24- ,31- 29- ,32- 30- /t41- ,44?,45- ,46?,47?,48?,49- /m1/s1 |
LJEBGLSLXVEYMV-FTIARRKHSA-N |
[C@@H] 1(C(C(C([C@H] (C1O) O) O) O) O) OP(OC[C@@] (COC(CCC/C=C\C/C=C\C/C=C\CCCCCCCC) =O) (OC(CCC/C=C\C/C=C\C/C=C\CCCCCCCC) =O) [H] ) (O) =O |
|
1,2-Di(5Z,8Z,11Z-eicosatrienoyl)-rac-glycero-3-phospho-(1'-myo-inositol)
|
HMDB
|
1,2-Dimeadoyl-rac-glycero-3-phosphoinositol
|
HMDB
|
[(2R)- 2,3- bis[(5Z,8Z,11Z)- icosa- 5,8,11- trienoyloxy]propoxy]({[(1s,3R)- 2,3,4,5,6- pentahydroxycyclohexyl]oxy})phosphinic acid
|
HMDB
|
Phosphatidylinositol(20:3/20:3)
|
HMDB
|
Phosphatidylinositol(20:3n9/20:3n9)
|
HMDB
|
Phosphatidylinositol(20:3w9/20:3w9)
|
HMDB
|
Phosphatidylinositol(40:6)
|
HMDB
|
PI(20:3/20:3)
|
HMDB
|
PI(20:3n9/20:3n9)
|
HMDB
|
PI(20:3w9/20:3w9)
|
HMDB
|
PI(40:6)
|
HMDB
|
PIno(20:3/20:3)
|
HMDB
|
PIno(20:3n9/20:3n9)
|
HMDB
|
PIno(20:3w9/20:3w9)
|
HMDB
|
PIno(40:6)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|